Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata, Masaaki Iwata, Noriko Kudo, Satoru Oishi, Takeya Takizawa, Kiyotaka Nemoto, Yuka Yasuda, Hiromi Tagata, Takashi Tsuboi, Naohisa Tsujino, Naoki Hashimoto, Yuki Matsui, Hikaru Hori, Hidenaga Yamamori, Nobuhiro Sugiyama, Taro Suwa, Taishiro Kishimoto, Akitoyo HishimotoMasahide Usami, Ryuji Furihata, Kunihiro Iwamoto, Hiroshige Fujishiro, Toshinori Nakamura, Kentaro Mizuno, Takahiko Inagaki, Eiichi Katsumoto, Hiroaki Tomita, Kazutaka Ohi, Hiroyuki Muraoka, Kiyokazu Atake, Hitoshi Iida, Tatsuya Nagasawa, Junichi Fujita, Satoshi Yamamura, Toshiaki Onitsuka, Atsunobu Murata, Yoichiro Takayanagi, Hokuto Noda, Yukiko Matsumura, Kenji Takezawa, Jun ichi Iga, Kayo Ichihashi, Kazuyoshi Ogasawara, Hisashi Yamada, Ken Inada, Ryota Hashimoto

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Aim: Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. Methods: Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants’ clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants’ demographics and their clinical knowledge scores. Results: The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. Conclusion: Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants’ clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.

Original languageEnglish
Pages (from-to)642-648
Number of pages7
JournalPsychiatry and Clinical Neurosciences
Volume73
Issue number10
DOIs
Publication statusPublished - 2019 Oct 1
Externally publishedYes

Keywords

  • EGUIDE project
  • educational program
  • major depressive disorder
  • schizophrenia
  • treatment guideline

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study'. Together they form a unique fingerprint.

Cite this